110 likes | 236 Vues
In 2010, Norway spent 130 billion NOK on healthcare, ranking high globally in per capita spending. Despite this investment, Norwegians often lack access to the newest and costliest medications. The financial implications of treating serious conditions, such as Pompe disease and multiple sclerosis (MS), raise important ethical questions about the value of life and the allocation of resources. This analysis compares the costs associated with various patient demographics, including drug addicts and chronic illness sufferers, and examines the implications of our healthcare choices in a society where life expectancy is rising.
E N D
Financial priorities in medicineHow much can a patient cost?By Susanna Valland Tim Eskestrand
Norway • Will spend 130 billion NOK on healthcare in 2010 ( 390 billion CZK ) • One of the countries spending the most money on health pr. person in the world • Norwegians still don’t benefit from the newest and most expensive medicines
Examples • Pompe disease, 4 mill NOK, 12 mill CZK • Drug addict, 1 mill NOK, 3 mill CZK • Nursing home, 0.5 mill NOK, 1.5 mill CZK • MS medications, 108 000 NOK, 300 000 CZK
Drug addicts Cons • It’s a “choice” • No contribution to the community • High risk of relapse • Expensive Pros • Numbers can be affected • Recovered addicts • Stormberg AS
Specific diseases( MS patient ) Pros • It’s not a choice • Drugs can give the patient a normal life • Tax will cover expenses Cons • Expensive
We live longer • 1 hospital bed costs 8500 NOK/night • Increased life expectancy, ♀ 83, ♂ 79 • Increased average age, 39 • Dying at home is cheaper
Sources • http://www.dagensmedisin.no/nyheter/2010/02/25/hvor-mye-kan-en-pasient-ko/index.xml • http://www.adressa.no/meninger/article1474173.ece • Http://e24.no/naeringsliv/article2553088.ece • http://www.ssb.no/befolkning